Sandoz

Sandoz

Sandoz

Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend peoples lives.
Founded
1886
Follow us
Alexa global traffic share
Team Size
10000+
Employees
Location
Headquarters
VCCircle

Aurobindo Pharma’s $1-bn deal with Novartis unit Sandoz collapses

Reuters Top News

Novartis raises 2019 guidance, helped by Sandoz generics unit

MedCity News

Sandoz gets into the weeds with cannabis medical product manufacturer Tilray

Paul Tunnah

Digital health round-up - government and Sandoz recognise trailblazing projects

Health Technology
Bloomberg

Stada Names Sandoz Manager as Fifth CEO Since 2016

Strategy